Haag-Streit USA launches surgical division

Article

Haag-Streit USA has launched a new division, Haag-Streit Surgical, which will market a line of surgical microscopes already widely used in Europe.

Mason, Ohio-Haag-Streit USA announces the launch of a new division: Haag-Streit Surgical. The new unit will market a line of surgical microscopes that already enjoy significant market share throughout Europe. Formerly known as Möller-Wedel, the devices are now being offered in the U.S. under the new Haag-Streit Surgical brand.

“This line of surgical microscopes is well established in Europe,” said Haag-Streit USA CEO Ernest Cavin. “Now American ophthalmologists, neurosurgeons, and otolaryngologists will have better access to devices with a proven record of superior optics. This launch offers a new choice for the marketplace-one that will benefit doctors and their patients.”

To introduce the product line to U.S. doctors, Haag-Streit Surgical launched a network of independent sales representatives. Haag-Streit is leveraging its existing toll-free number and Web site to connect interested doctors with product information.

The surgical microscope line, including Haag-Streit’s Hi-R NEO 900, will be on display at the Haag-Streit booth at industry conferences throughout 2013. The Hi-R NEO 900 is a universal microscope for surgical procedures, such as ophthalmology, that require vertical observation. Its exceptionally large stereo base provides maximal depth perception and clear zoom illumination delivers safe, bright light.

More information is available at www.haag-streit-usa.com, or by calling 800/787-5426.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.